Schedule 13D ownership disclosure

ALPINE IMMUNE SCIENCES INC

Security class unavailable · CUSIP: 02083G100

Event date: 2018-08-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-18-001083
Form type
SC 13D/A
Filer
ALPINE IMMUNE SCIENCES, INC.
CIK
CIK 1626199
Filed
Aug 20, 2018
Reporting period
Aug 15, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub